Meyka AI API is live for developers.Start building.
Advertisement
Verona Pharma plc

Verona Pharma plc (VRNA) Stock Overview

Explore Verona Pharma plc’s financial performance, market position, analyst ratings, and future outlook.

VRNA●NASDAQ
HealthcareBiotechnology
$106.91
$0.12(0.11%)
U.S. Market opens in 63h 12m
Advertisement

Verona Pharma plc (VRNA)

Meyka AI Score

Z

Key Financials

Market Cap72.7B
P/E Ratio-295.69
EPS (TTM)$-1.04
ROE-0.13%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

VRNA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Verona Pharma plc (VRNA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -295.69 and a market capitalization of 72.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.44%
6-Month Change
52.58%
Year-to-Date (YTD) Change
121.80%
1-Year Change
184.41%
3-Year Change
747.15%
5-Year Change
1684.81%
All-Time (Max) Change
691.93%

Contact Information

https://www.veronapharma.com
44 20 3283 4200
3 More London Riverside, London, NaN, SE1 2RE

Company Facts

2,090 Employees
IPO DateApr 28, 2017
CountryGB

Frequently Asked Questions